A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain. (2012)

First Author: Lalatsa A
Attributed to:  Technologies for the Treatment of Brain Diseases funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/mp300009u

PubMed Identifier: 22574705

Publication URI: http://europepmc.org/abstract/MED/22574705

Type: Journal Article/Review

Volume: 9

Parent Publication: Molecular pharmaceutics

Issue: 6

ISSN: 1543-8384